Berry Genomics Co.,Ltd

Equities

000710

CNE000000PN7

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
7.17 CNY -3.63% Intraday chart for Berry Genomics Co.,Ltd -15.05% -37.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Berry Genomics to Sell Fujian Industrial Park Assets to New JV MT
Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Berry Genomics's Controlling Shareholder Plans to Unload up to 4% Company Stakes CI
Huang Qiwei cancelled the acquisition of a 3.81% stake in Berry Genomics Co.,Ltd from Gao Yang and Hou Ying. CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Berry Genomics Co.,Ltd Announces Executive Appointments CI
Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Huang Qiwei agreed to acquire a 3.81% stake in Berry Genomics Co.,Ltd from Gao Yang and Hou Ying for approximately CNY 160 million. CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Berry Genomics Co.,Ltd(XSEC:000710) dropped from S&P Global BMI Index CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Berry Genomics Appoints New CFO MT
Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PacBio and Berry Genomics Announces Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China CI
Wang Tianyi agreed to acquire 2.6226% in Berry Genomics Co.,Ltd from Gao Yang and Hou Ying for CNY 130 million. CI
Berry Genomics Co.,Ltd(SZSE:000710) dropped from Shenzhen Stock Exchange Component Index CI
Berry Genomics Co.,Ltd(SZSE:000710) dropped from Shenzhen Stock Exchange Component A Share Index CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Alibaba Health Information Technology : , Berry Genomics to Build Early Cancer Screening System MT
Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Berry Genomics Co.,Ltd cancelled the transaction announced on August 13, 2020 CI
Chart Berry Genomics Co.,Ltd
More charts
Berry Genomics Co Ltd is a company mainly engaged in medical testing related services. The Company's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome sequencing and whole genome sequencing. The medical testing services business include tumor genetic testing services, genetic disease genetic testing services and reproductive health testing services. The Company sells a range of reagents and equipment, including NextSeq CN500 gene sequencer and general reagents for sequencing reactions.
Calendar
More about the company

Annual profits - Rate of surprise